Decision Resources
Recent developments announced by Decision Resources
Published in Health Insurance Week, October 14th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Decision Resources.
Report 1: Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that although Sanofi-Aventis's eplivanserin and Actelion's ACT- 078573 will be market leaders by 2016, the insomnia market is not likely to sustain multiple "me-too" drugs that lack definable safety or efficacy advantages.
The new Pharmacor report Insomnia finds that the 5-HT2 antagonist eplivanserin and the orexin receptor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Insurance Week
More Articles from Health Insurance Week
- Life Sciences
Studies from Children's Hospital have provided new data on life sciences in children - Aegis Therapies
Aegis Therapies Acquires Gulf Coast Therapy Associates, Inc. - Agency for Healthcare Research and Quality
One in Six Americans Never Has Had Their Cholesterol Checked - Army Medical Department
Army Expands Medical and Dental School Scholarship Benefits - Avivia Health
Avivia Health from Kaiser Permanente Launches Health and Productivity Optimization Product - AvMed Health Plans
The Village Announces New Administrator - More from this issue of Health Insurance Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
